Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver

Clinical trial NCT03005002 · COMPLETED

Trial details

NCT number: NCT03005002
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Carcinoma in the Liver MLH1 Gene Mutation MSH6 Gene Mutation PMS2 Gene Mutation Stage IV Colorectal Cancer Stage IVA Colorectal Cancer Stage IVB Colorectal Cancer

Start date: 2017-06-28
Primary completion: 2019-11-26
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.